Studying Suranjan bulb (Colchicum luteum) to improve gout symptoms through lab analysis and clinical trials.

Assessing the potential of Suranjana (colchicum luteum Baker) corm: A pharmacognostical and clinical studies in Vatarakta (Gout). - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100329

Enrollment

Registered

2026-01-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical sign and symptoms of Vatarakta (Gout). Patient of either sex aged between 18-65 years. Patient of having Mono Sodium Urate (Serum Uric Acid) is higher or equal to 0.40 mmol/L (7 mg/dL in males, 6 mg/dL in females).

Exclusion criteria

Exclusion criteria: Patients having diebetes mellitus. Patients having other symptemic disorders which interfere with the course of treatment. Pregnant and lactating women. Patients having Hb below 8%.

Design outcomes

Primary

Measure	Time frame
Reduction in signs and symptoms of Vatarakta (Gout) and statistically significant lowering of Serum Uric acidTimepoint: total 6 months study with follow up after every 15 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactProf B Ram

Banaras Hindu University

ganakwar.rama@bhu.ac.in09545762751

Outcome results